6LBA 177-Lu-Dotatate significantly improves progression-free survival in patients with midgut neuroendocrine tumours: Results of the phase III NETTER-1 trial

Saved in:
Bibliographic Details
Published inEuropean journal of cancer (1990) Vol. 51; p. S710
Main Authors Strosberg, J, Wolin, E, Chasen, B, Kulke, M, Bushnell, D, Caplin, M, Baum, R.P, Mittra, E, Hobday, T, Hendifar, A, Oberg, K, Lopera Sierra, M, Ruszniewski, P, Kwekkeboom, D
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.09.2015
Subjects
Hematology, Oncology and Palliative Medicine
Online AccessGet full text

Cover

More Information
ISSN:0959-8049
1879-0852
DOI:10.1016/S0959-8049(16)31929-3